spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  montelukast 

 HSMN NewsFeed - 24 May 2022
Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Sep 2018
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to product/label mix-up
Biopharmaceuticals FDA Product Recall
 HSMN NewsFeed - 31 Aug 2018
FDA announces voluntary recall of Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles
Biopharmaceuticals FDA Product Recall
 HSMN NewsFeed - 22 Sep 2014
Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Aug 2009
Teva Provides Update on Generic Singulair(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Aug 2009
Merck Wins SINGULAIR(R) Patent Infringement Lawsuit
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 May 2009
Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Jan 2009
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2008
Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
Biopharmaceuticals
 HSMN NewsFeed - 28 Aug 2007
Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2007
New Indication for SINGULAIR(R) (montelukast sodium) Approved to Prevent Exercise-induced Bronchoconstriction
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Nov 2006
Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
montelukast
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.